Sudeep Pharma IPO Allotment Status: 7 Powerful Things to Know

November 20, 2025 Navya

Spread the love

The Sudeep Pharma IPO allotment status will be published on 26 November 2025. It shows whether your application received shares and confirms the official outcome, which decides if shares are credited to your demat account or refunds are processed to your bank.

Check the allotment status online using PAN, application number or DP/Client ID via the registrar, BSE or NSE portals. Knowing the result helps you plan next steps – expect share credits, refund initiation dates, and contact your broker promptly if there are discrepancies.

Table of Contents

Sudeep Pharma IPO Details

Here is the quick overview of the key dates and details for the Sudeep Pharma IPO.

Sudeep Pharma IPO Details	Details
IPO Open Date	21 November 2025
IPO Close Date	25 November 2025
Tentative Allotment	26 November 2025
Initiation of Refunds	27 November 2025
Credit of Shares to Demat	27 November 2025
Tentative Listing Date	28 November 2025
Face Value	₹1 per share
Issue Price Band	₹563 – ₹593 per share
Lot Size	25 shares
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Lead Manager	ICICI Securities Ltd.
Registrar	MUFG Intime India Pvt. Ltd.

How to Check Sudeep Pharma IPO Allotment Status?

Here are the detailed steps to check Sudeep Pharma IPO Allotment Status:

Registrar website (MUFG Intime India Pvt. Ltd.): Open the registrar’s allotment page, choose Sudeep Pharma Ltd IPO, enter PAN or Application Number or DP/Client ID, then submit to view the allotment.
NSE allotment page: Go to NSE – IPO/Allotment section, pick the Sudeep Pharma IPO, enter your PAN or Application Number or DP ID, and click search to see the result.
BSE allotment page: Visit BSE – IPO – Allotment Status, select the Sudeep Pharma issue, fill in PAN/Application No/DP ID and submit to check allotment.
Broker / Trading app: Many brokers display allotment under your IPO application history; check the IPO tab in your trading app or web portal for a direct status update.
SMS / Email confirmation: After allotment the registrar or your broker usually sends an SMS/email confirming allotment, share credits or refund details – keep these for reference.
If no result or discrepancy: Note down your Application Number and PAN, contact the registrar (MUFG Intime) or your broker with these details and the allotment screen snapshot for help.

What Happens After IPO Allotment?

After the Sudeep Pharma IPO allotment is finalised, investors either receive shares or get their money unblocked. If allotted, the shares are credited to your demat account on the scheduled date. If not, your bank releases the blocked amount automatically without any action required.

Sudeep Pharma IPO Listing Date

Shares of Sudeep Pharma are expected to list on 28 November 2025. The listing date is when shares begin trading publicly on NSE and BSE, marking liquidity for investors and reflecting initial market pricing versus the issue price.

On listing day watch live quotes, broker notifications and order execution carefully. The listing can cause immediate gains or volatility, so compare price movement with your investment goals and account for transaction costs before deciding to sell or hold.

Sudeep Pharma IPO GMP

The latest Sudeep Pharma IPO GMP is ₹130, indicating strong grey-market demand before listing. This premium suggests the stock may list higher than its issue price, reflecting positive sentiment among early traders and short-term investors ahead of market debut.

With a ₹130 GMP, expectations for listing gains increase, but GMP is unofficial and fluctuates quickly. Investors should use it only as a sentiment indicator and combine it with fundamentals, subscription data and broader market trends before making listing-day decisions.

Sudeep Pharma IPO DRHP

The Draft Red Herring Prospectus (DRHP) for Sudeep Pharma was filed in June 2025. The DRHP contains company business details, financials, risk factors and the IPO structure, providing the foundational information investors need before deciding to apply.

Read the DRHP to check revenue trends, profitability, related-party transactions and planned use of proceeds. These items explain growth plans and risks, helping you assess whether Sudeep Pharma’s valuation fits your investment horizon before applying.

Sudeep Pharma IPO Subscription Status

Subscription status will be published after the issue closes on 25 November 2025 and shows bids received across retail, HNI and QIB categories. It measures demand – high oversubscription often means lower allotment ratios and potential listing premiums.

You can check the Sudeep Pharma IPO subscription status on the NSE and BSE websites during the issue period. These platforms update live bidding figures for retail, HNI and QIB segments, helping investors track demand and understand how actively the IPO is being subscribed.

Risks and Challenges for Investors of Sudeep Pharma Ltd IPO

Business & operational risk: Pharma operations face manufacturing, quality control and supply-chain issues that can affect revenue and margins.
Regulatory risk: Drug approvals, pricing rules, inspections and changing compliance requirements can materially impact the company’s prospects.
Financial performance risk: If revenue growth or profitability is weak versus IPO expectations, the stock may underperform after listing.
Market / listing volatility: Listing-day price swings, influenced by GMP and subscription, can cause quick gains or losses for short-term traders.
Competition & concentration risk: Strong competitors or dependence on a few products/customers can hurt future revenue stability.
Valuation & price-band risk: The issue price may be high relative to fundamentals; overpaying reduces margin of safety.
Sector & macro risks: Interest rates, currency moves, or broader market sell-offs can pressure IPO performance even when company fundamentals are fine.

How to invest in Sudeep Pharma Limited IPO?

Ensure KYC, demat & trading accounts – Have an active demat account, completed KYC and linked bank UPI or ASBA-capable account before applying.
Check IPO details: Note the issue price band (₹563–₹593), lot size (25 shares) and open/close dates; calculate how many lots you want to apply for.
Apply via broker/trading app: Log into your trading account – IPO section – select Sudeep Pharma Ltd – choose number of lots and enter bid price (or cut-off) →- submit application.
Choose payment method (UPI/ASBA): If using UPI, approve the UPI mandate when your bank prompts; if using ASBA, funds are blocked in the bank account until allotment/refund.
Note & save application details – After applying, save your Application Number and confirm the blocked amount; these help track allotment and refunds.
Track subscription & allotment: Monitor subscription status during/after the issue, then check allotment on registrar / NSE / BSE or your broker after the tentative allotment date.
Post-allot actions – if allotted, shares will be credited to your demat and you’ll receive confirmation; if not allotted, refunds are processed to your bank (check refund date) – decide whether to hold or sell on listing day.

Conclusion – Sudeep Pharma Ltd IPO

Sudeep Pharma Ltd IPO opens on 21 November 2025 and closes on 25 November 2025.
The Sudeep Pharma Ltd IPO allotment status will be announced on 26 November 2025.
Refunds for non-allottees of the Sudeep Pharma Ltd IPO begin on 27 November 2025.
Shares allotted under the Sudeep Pharma Ltd IPO will be credited to demat accounts on 27 November 2025.
The Sudeep Pharma Ltd IPO listing date is 28 November 2025, when shares start trading on BSE and NSE, giving investors a chance to evaluate listing gains or decide to hold long-term.
Sudeep Pharma Ltd IPO GMP is ₹130, this shows strong market sentiment, but investors should consider fundamentals, subscription demand and risk factors instead of relying solely on grey-market trends.
The Sudeep Pharma Ltd IPO priced at ₹563-₹593 per share offers a structured book-building process, giving investors a balanced view of valuation and demand before placing bids in their preferred category.
MUFG Intime India Pvt Ltd serves as registrar for the Sudeep Pharma Ltd IPO.

FAQ – Sudeep Pharma IPO Allotment Status

When will the Sudeep Pharma IPO allotment status be announced?

The allotment for Sudeep Pharma IPO is expected to be finalised on 26 November 2025.

What is the Sudeep Pharma Limited IPO?

Sudeep Pharma Ltd IPO is a main-board book-built issue of up to ₹895 crore, comprising a fresh issue of about ₹95 crore and an offer for sale of ~₹800 crore.

What is the open and close date of Sudeep Pharma IPO?

Sudeep Pharma IPO opens on 21 November 2025 and closes on 25 November 2025.

What is the Sudeep Pharma Ltd IPO size?

The total issue size of Sudeep Pharma Ltd IPO is about ₹895 crore, covering ~1,50,92,750 shares.

How to invest in Sudeep Pharma IPO?

Log into your demat and trading account and go to the IPO section.
Select the Sudeep Pharma IPO, choose number of lots (minimum 25 shares) at the price band (₹563-₹593) and submit your bid via ASBA or UPI.

Ensure the funds are blocked in your bank account and the UPI mandate is approved before the closing date.

How can I check the Sudeep Pharma IPO allotment status online?

Visit the registrar’s website (MUFG Intime India Pvt Ltd) and select the Sudeep Pharma IPO from the dropdown.
Enter required identification details and submit the form to view your allotment status.
You may also view this via your broker’s IPO application section once allotment results are published.

What details are required to check the Sudeep Pharma IPO allotment status?

Your PAN number.
Your Application Number or DP / Client ID (demat account number).

Select the company name (“Sudeep Pharma Limited IPO”) from the dropdown list on the registrar’s site.

What happens if I don’t get any shares in the Sudeep Pharma Limited IPO?

If you are not allotted any shares, the blocked funds will be released back to your bank account and you will not receive shares.

When will the refund be processed for un-allotted investors?

Refunds for un-allotted applicants of Sudeep Pharma IPO are expected to be initiated on 27 November 2025.

When will the Sudeep Pharma IPO shares be credited to the Demat account?

Shares allotted should be credited to your demat account by 27 November 2025.

What is the Sudeep Pharma IPO listing date?

Sudeep Pharma shares are expected to list on the National Stock Exchange of India and the Bombay Stock Exchange on 28 November 2025.

Which registrar is handling the Sudeep Pharma IPO allotment process?

The registrar for Sudeep Pharma IPO is MUFG Intime India Pvt Ltd.

Can I check the Sudeep Pharma IPO allotment status on NSE or BSE websites?

Yes – you can also check the allotment status via the BSE or NSE websites by entering your PAN or application number.

What is the lot size for the Sudeep Pharma IPO?

The minimum lot size for the Sudeep Pharma IPO is 25 shares.

How will I know if I have received the Sudeep Pharma Limited IPO shares?

You will see the allotted shares show up in your demat account and a confirmation message (SMS/email) from your broker once credits are done around 27 November.